Systemic sclerosis is an uncommon condition but the associated complications can have severe adverse effects on a patient’s quality of life and survival. A multimodal, multidisciplinary approach to management of disease manifestations is essential.
- Systemic sclerosis (SSc), or scleroderma, is a multisystem autoimmune disease characterised by vasculopathy and fibrosis.
- Adult-onset Raynaud’s phenomenon or Raynaud’s phenomenon complicated by digital ulceration or infarction should prompt consideration of connective tissue disorders including SSc.
- Early identification of severe, life-threatening organ manifestations can result in improved quality of life and survival.
- Management of patients with SSc is multifaceted and dependent on individual disease manifestations.
Picture credit: © Phototake/Bodell Communications/Diomedia.com